EP4202394A1 - Verwendung einer schrumpfbaren biopolymerfaser als sensor - Google Patents

Verwendung einer schrumpfbaren biopolymerfaser als sensor Download PDF

Info

Publication number
EP4202394A1
EP4202394A1 EP22213341.5A EP22213341A EP4202394A1 EP 4202394 A1 EP4202394 A1 EP 4202394A1 EP 22213341 A EP22213341 A EP 22213341A EP 4202394 A1 EP4202394 A1 EP 4202394A1
Authority
EP
European Patent Office
Prior art keywords
fiber
shrinkage
biopolymer
solvent
seconds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22213341.5A
Other languages
English (en)
French (fr)
Inventor
Jens Klein
Lin RÖMER
Michael BERGFELD
Josef Lauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMSilk GmbH
Original Assignee
AMSilk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AMSilk GmbH filed Critical AMSilk GmbH
Publication of EP4202394A1 publication Critical patent/EP4202394A1/de
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01M—TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR
    • G01M3/00—Investigating fluid-tightness of structures
    • G01M3/02—Investigating fluid-tightness of structures by using fluid or vacuum
    • G01M3/04—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point
    • G01M3/042—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point by using materials which expand, contract, disintegrate, or decompose in contact with a fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D163/00—Coating compositions based on epoxy resins; Coating compositions based on derivatives of epoxy resins
    • C09D163/10—Epoxy resins modified by unsaturated compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/02—Emulsion paints including aerosols
    • C09D5/022—Emulsions, e.g. oil in water
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01M—TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR
    • G01M3/00—Investigating fluid-tightness of structures
    • G01M3/02—Investigating fluid-tightness of structures by using fluid or vacuum
    • G01M3/04—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings

Definitions

  • the present invention relates to the use of a shrinkable biopolymer fiber as sensor.
  • the sensor allows to determine the authenticity of a product.
  • the sensor allows to determine the presence of a solvent.
  • the present invention relates to a method for determining the authenticity of a product.
  • the present invention relates to a method for determining the presence of a solvent.
  • the present invention relates to the use of a shrinkable biopolymer fiber for shaping an object.
  • the present invention relates to a method for shaping an object.
  • the present invention relates to the use of a shrinkable biopolymer fiber as suture material or wound dressing.
  • Counterfeit consumer goods are a common problem in this days. Counterfeit consumer goods are goods made or sold under another's brand name without the brand owner's authorization. They exist in virtually every area, including food, beverages, clothes, shoes, pharmaceuticals, electronics, auto parts, toys, and currency. The spread of counterfeit goods is worldwide, and in 2008 a study by the International Chamber of Commerce (ICC) estimated the global value of all counterfeit goods reached $650 billion every year. The same study projected that in 2015 the upper bound of the global value of counterfeit and pirated goods could be $1.77 trillion.
  • ICC International Chamber of Commerce
  • Packaging can be engineered to help reduce the risks of package pilferage or the theft and resale of products: Some package constructions are more resistant to pilferage and some have pilfer indicating seals. Counterfeit consumer goods, unauthorized sales (diversion), material substitution and tampering can all be reduced with these anti-counterfeiting technologies. Packages may include authentication seals and use security printing to help indicate that the package and contents are not counterfeit; these too are subj ect to counterfeiting. Packages can also include anti-theft devices, such as dye-packs, RFID tags, or electronic article surveillance tags that can be activated or detected by devices at exit points and require specialized tools to deactivate.
  • anti-theft devices such as dye-packs, RFID tags, or electronic article surveillance tags that can be activated or detected by devices at exit points and require specialized tools to deactivate.
  • Anti-counterfeiting technologies that can be used with packaging include, for example, taggant fingerprinting (uniquely coded microscopic materials that are verified from a database), encrypted micro-particles (unpredictably placed markings (numbers, layers, and colors) not visible to the human eye), UV printing (marks only visible under UV light) or serialized barcodes.
  • a reduced product quality can be a serious public health and safety problem.
  • a reduced product quality may have a negative impact on the functional capability of a product.
  • One of the most common events leading to reduced product quality is the entry of liquid/moisture into a product or that a product becomes wet.
  • a drug which has become wet does not have an adequate quality anymore. It may be ineffective in treatment.
  • an electronical device which has become wet does not have an adequate quality anymore. It may function insufficiently or may not function anymore.
  • Liquid/moisture sensors/indicators which are currently on the market indicate, for example, the liquid/moisture stage though a change in color if a specific liquid/moisture level is exceeded.
  • the color reaction depends on the absorption of water.
  • Most known is cobalt chloride blended silica-gel. It changes its color from violet to pink.
  • Cobalt chloride is, however, toxic to the user/consumer.
  • Alternative non-toxic systems are often expensive.
  • the inventors of the present patent application surprisingly found that the ability of a biopolymer fiber to shrink allows its use as a sensor. They noticed that said shrinkable biopolymer fiber allows on the one hand side to determine the authenticity of a product and on the other hand side the presence of a solvent in an effective, inexpensive, and user friendly way.
  • the present invention relates to the use of a shrinkable biopolymer fiber as sensor.
  • the sensor allows to determine the authenticity of a product.
  • the sensor allows to determine the presence of a solvent.
  • the present invention relates to a method for determining the authenticity of a product comprising the steps of:
  • the present invention relates to a method for determining the presence of a solvent comprising the steps of:
  • the present invention relates to the use of a shrinkable biopolymer fiber for shaping an object.
  • the present invention relates to a method for shaping an object comprising the steps of:
  • the present invention relates to the use of a shrinkable biopolymer fiber as suture material.
  • the present invention relates to the use of a shrinkable biopolymer fiber as wound dressing.
  • the terms used herein are defined as described in " A multilingual glossary of biotechnological terms: (IUPAC Recommendations)", Leuenberger, H.G.W, Nagel, B. and Kölbl, H. eds. (1995), Helvetica Chimica Acta, CH-4010 Basel, Switzerl and).
  • sensor refers to an object/a material whose capability is to detect events or changes in its environment and, then, provide a corresponding output. More specifically, the term “sensor”, as used herein, refers to an object/a material that reacts after contact with a liquid or moisture. This reaction is optically recognizable. It is expressed in a shape change, preferably a shrinkage.
  • biopolymer refers to a large molecule or macromolecule of biological origin which is composed of many repeated subunits/repeating building blocks.
  • the biopolymer may be a polypeptide, e.g. a recombinant polypeptide. Said polypeptide comprises repeated subunits/repeating building blocks made of amino acids.
  • the polypeptide is a silk polypeptide, more preferably a spider silk polypeptide.
  • polypeptide and “protein” are used interchangeably in the context of the present invention. They refer to a long peptide-linked chain of amino acids, e.g. one that is at least 40 amino acids long.
  • silk polypeptide refers to a polypeptide which shows, in comparison to other polypeptides, a quite aberrant amino acid composition.
  • a silk polypeptide possess large quantities of hydrophobic amino acids such as glycine or alanine, but, for example, no (or only very little) tryptophan.
  • a silk polypeptide contains highly repetitive amino acid sequences or repetitive units (repeat units, modules), especially in their large core domain.
  • peptide motif and "consensus sequence” can be used interchangeably herein.
  • the silk consensus sequences can be grouped into four major categories: GPGXX, GGX, A x or (GA) n and spacers. These categories of peptide motifs in silk polypeptides have been assigned structural roles. For example, it has been suggested that the GPGXX motif is involved in a ⁇ -turn spiral, probably providing elasticity. The GGX motif is known to be responsible for a glycine-rich 3i-helix.
  • both GPGXX and GGX motifs are thought to be involved in the formation of an amorphous matrix that connects crystalline regions, thereby providing elasticity of the fiber.
  • Alanine-rich motifs typically contain 6-9 residues and have been found to form crystalline ⁇ -sheets.
  • the spacers typically contain charged groups and separate the iterated peptide motifs into clusters.
  • the silk polypeptide is a spider silk polypeptide. More preferably, the silk polypeptide, e.g. spider silk polypeptide, is a recombinant polypeptide.
  • biopolymer fiber refers to a substance that is significantly longer than it is wide. It comprises or consists of biopolymers.
  • biopolymer fiber further refers to a material comprising or consisting of biopolymers that are continuous filaments, staple fibers, or are in discrete elongated pieces.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0,5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • biopolymer fiber also encompasses a monofilament or multifilament biopolymer fiber.
  • a monofilament biopolymer fiber is composed of a single (mono)filament.
  • a multifilament biopolymer fiber is composed of a number of (mono)filaments.
  • a multifilament fiber may be composed of between 2 and 1000 (mono)filaments, e.g.
  • biopolymer fiber further encompasses single-drawn and multi-drawn (e.g. double-drawn) fibers. Said fibers have been stretched one or more times during their preparation process, in particular wet-spinning process.
  • An exemplarily process for processing a biopolymer into fibers which may be used in the present invention is described in WO 2014/037453 .
  • biopolymer fiber also covers a biopolymer fiber which comprises/is blended with one or more additional polymers such as additional biopolymers and/or additional plastic polymers.
  • the biopolymer fiber may comprise/may be blended with one or more additional biopolymers selected from the group consisting of a (recombinant) silk polypeptide (e.g. a (recombinant) spider silk polypeptide, a(n) (recombinant) insect silk polypeptide, and/or a (recombinant) silk worm (Bombyx mori) silk polypeptide), collagen (e.g. natural and/or recombinant collagen), keratin, and polyolefins (e.g.
  • a silk polypeptide e.g. a (recombinant) spider silk polypeptide, a(n) (recombinant) insect silk polypeptide, and/or a (recombinant) silk worm (Bombyx mori) silk polypeptide
  • collagen
  • the additional plastic polymer may be polyacrylate.
  • the (recombinant) silk polypeptide fiber may comprise a (recombinant) silk polypeptide as biopolymer and collagen as additional biopolymer
  • the (recombinant) silk polypeptide fiber may comprise a (recombinant) silk polypeptide as biopolymer and keratin as additional biopolymer
  • the (recombinant) spider silk polypeptide fiber may comprise a (recombinant) spider silk polypeptide as biopolymer and a(n) (recombinant) insect silk polypeptide as additional biopolymer
  • the (recombinant) spider silk polypeptide fiber may comprise a (recombinant) spider silk polypeptide as biopolymer and a (recombinant) silk worm
  • the content of the one or more additional polymers such as biopolymers and/or plastic polymers in the biopolymer fiber is less than 66% by weight, more preferably less than 50% by weight, less than 30% by weight, or less than 20% by weight, and even more preferably less than 15% by weight, less than 10% by weight, less than 5% by weight, or less than 1% by weight.
  • the content of the one or more additional polymers in the biopolymer fiber is at least 0.1% by weight, at least 1% by weight, at least 5% by weight, at least 10% by weight, at least 15% by weight, at least 20% by weight, at least 30% by weight, or at least 50% by weight, and/or less than 66% by weight, less than 50% by weight, less than 30% by weight, less than 20% by weight, less than 10% by weight, less than 5% by weight, or less than 1% by weight.
  • the content of the one or more additional polymers in the biopolymer fiber is in the range of between 0.1 and 66% by weight, between 1% and 66% by weight, between 5% and 50% by weight, between 5% and 30% by weight, between 5% and 20% by weight, or between 5% and 10% by weight.
  • Such biopolymer fibers may enhance any desired characteristics, e.g. appearance, softness, weight, durability, water-repellent properties, improved cost-of-manufacture, Said characteristics may be useful in medical, industrial, or commercial applications.
  • shrinkable biopolymer fiber refers to a biopolymer fiber the length of which is shrinkable/reducible after first contact with a chemical, e.g. a solvent.
  • a chemical e.g. a solvent
  • the entire shrinkage process (which starts with the first contact with a chemical, e.g. a solvent, and ends with the conclusion of the shrinkage) completely takes place in the chemical, e.g. the solvent.
  • the length of the biopolymer fiber is shrinkable/reducible by at least 10%, more preferably by at least 15%, even more preferably by at least 25%, and most preferably by at least 35%, with regard to its total length after first contact with a chemical, e.g. a solvent.
  • shrinkable biopolymer fiber also refers to a biopolymer fiber which shrinkage (process) starts after a duration after first contact with a chemical, e.g. a solvent, and is concluded after a time range.
  • a chemical e.g. a solvent
  • shrinkage process starts after a duration after first contact with a chemical, e.g. a solvent, and ends with the shrinkage conclusion after a time range
  • the length of the biopolymer fiber is shrinked/reduced by at least 10%, more preferably by at least 15%, even more preferably by at least 25%, and most preferably by at least 35%, with regard to its total length after first contact with the chemical, e.g. the solvent.
  • the fiber may be a fiber as produced in WO 2014/037453 .
  • solvent refers to an aqueous solution or a solution comprising alcohol. It is preferred that the aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O. In another preferred embodiment the water may be piped water, rainwater, or seawater. It is also preferred that the alcohol is ethanol or isopropanol.
  • the term "after first contact with a chemical” in this context means that the biopolymer fiber as described herein is, after its production/formation, for the first time contacted with a chemical, e.g. a solvent.
  • a chemical e.g. a solvent.
  • the contact with a chemical, e.g. a solvent preferably results in a shrinkage of at least 10%, more preferably of at least 15%, even more preferably of at least 25%, and most preferably of at least 35%, with regard to its total length.
  • the shrinkage is irreversible.
  • irreversible shrinkage means that the fiber does not return to its original shape without external impacts/influences, in particular without a force application, e.g. fiber extrusion, fiber extension, or fiber stretching.
  • the term "product”, as used herein, refers to anything that can be offered to a market that might satisfy a want or need.
  • the product may be bought as raw material or sold as finished good.
  • the product may be a pharmaceutical product (e.g. a drug), a cosmetical product, an electronical product, a mechanical product, bags (e.g. handbags), footwear or clothing.
  • the product is preferably a fabric, e.g. a woven fabric or knitted fabric. More preferably, the fabric, e.g. the woven fabric or knitted fabric, is a garment.
  • authentication of a product refers to the determination whether a product is an original and not copied or an imitation.
  • label refers to a piece of polymer, e.g. cloth, which is affixed/attached to a product or is part of a product, or which is affixed/attached to the packaging of a product or part of the packaging comprising a product. It usually comprises written or printed information about the product.
  • the biopolymer fiber as described herein is preferably part of the label or hangtag.
  • the term "object”, as used herein, refers to any object which may be shaped by the shrinkable biopolymer fiber.
  • the object comprises or consists of a shrinkable biopolymer fiber.
  • the object comprises or consists of one single shrinkable biopolymer fiber.
  • the object comprises or consists of two or more shrinkable biopolymer fibers.
  • the object is a garment, apparel, a medical object, an orthopaedic object, a sports equipment including footwear, an outdoor equipment including footwear.
  • the term "object” also covers footwear.
  • the object is a fabric, e.g. a woven fabric or knitted fabric.
  • the fabric, e.g. the woven fabric or knitted fabric is a garment.
  • the garment may be a fashion, a sport, an outdoor, a medical, or an orthopaedic garment.
  • the garment may be fashion articles, fashion goods, shirts, socks, stockings, e.g. compression stockings, medical stockings, or support stockings, tights, e.g. support tights, pants, e.g. sport or outdoor pants, underwear, e.g. sport or outdoor underwear, gloves, caps, storm hoods, footwear or bandages.
  • object covers objects which comprise one or more biopolymer fibers and one or more additional polymer fibers such as additional biopolymer fibers or additional plastic polymer fibers.
  • the object may comprise additional biopolymer fibers selected from the group consisting of (recombinant) silk polypeptide fibers (e.g. (recombinant) spider silk polypeptide fibers, (recombinant) insect silk polypeptide fibers, and/or (recombinant) silk worm (Bombyx mori) silk polypeptide fibers), collagen fibers (e.g. natural fibers and/or recombinant collagen fibers), keratin fibers, and polyolefins fibers (e.g.
  • silk polypeptide fibers e.g. (recombinant) spider silk polypeptide fibers, (recombinant) insect silk polypeptide fibers, and/or (recombinant) silk worm (Bombyx mori) silk polypeptide fibers
  • collagen fibers e.g. natural
  • polylactic acid (PLA) fibers polycaprolactone (PCL) fibers, polylactat (PLA) fibers, and/or polyhydroxybutyrate (PHB)) fibers).
  • the additional plastic polymer fiber may be a polyacrylate fiber.
  • the object may comprise (i) (recombinant) silk polypeptide fibers as biopolymer fibers and collagen fibers as additional biopolymer fibers, (ii) (recombinant) silk polypeptide fibers as biopolymer fibers and keratin fibers as additional biopolymer fibers, (iii) (recombinant) spider silk polypeptide fibers as biopolymer fibers and (recombinant) insect silk polypeptide fibers as additional biopolymer fibers, or (iv) (recombinant) spider silk polypeptide fibers as biopolymer fibers and a (recombinant) silk worm (Bombyx mori) silk polypeptide fibers as additional biopolymer fibers.
  • the object is to at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 99%, or to 100% composed of (a) shrinkable biopolymer fiber(s) and/or the object is to at least 95%, at least 90%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40%, at least 30%, at least 20%, at least 10%, at least 5%, or at least 1% composed of one or more additional polymer fibers such as additional biopolymer fibers or additional plastic polymer fibers.
  • additional polymer fibers such as additional biopolymer fibers or additional plastic polymer fibers.
  • the object is to at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 99%, or to 100% composed of (a) shrinkable biopolymer fiber(s) and/or the object is to at least 50%, at least 40%, at least 30%, at least 20%, at least 10%, at least 5%, or at least 1% composed of one or more additional polymer fibers such as additional biopolymer fibers or additional plastic polymer fibers.
  • shape an object encompasses, for example, shrinking an object, compressing an object, and/or reducing the size of an object.
  • suture material refers to a material used to hold body tissues or body vessels together after injury or surgery.
  • the suture material is a suture, e.g. a surgical suture.
  • Applications of suture materials generally involve the use of a needle with an attached length of tread or fiber.
  • a number of different shapes, sizes, and thread material have been developed. Surgeons, physicians, dentist, podiatrists, eye doctors, registered nurses and other trained nursing personnel, medics, and clinical pharmacists typically engage in suturing. Surgical knots are used to secure sutures.
  • wound dressing refers to a pad or compress, in particular in a sterile form, to promote wound healing and protect the wound from further harm.
  • a wound dressing is designed to be in direct contact with the wound.
  • the wound dressing is self-adhesive.
  • the inventors of the present patent application surprisingly found that the ability of a biopolymer fiber to shrink allows its use as a sensor. They noticed that said shrinkable biopolymer fiber allows on the one hand side to determine the authenticity of a product and on the other hand side the presence of a solvent in an effective, inexpensive, and user friendly way.
  • the present invention relates to the use of a shrinkable biopolymer fiber as sensor.
  • Said sensor may be an authenticity sensor or a liquid/moisture sensor.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the biopolymer fiber has a specific shrinkage behavior.
  • Said specific shrinkage behavior is influenceable/influenced by temperature and/or pH. More particularly, the shrinkage (process) starts after first contact with a solvent/after first contact of a solvent with said fiber. Even more particularly, the shrinkage (process) starts after a duration after first contact with a solvent/after first contact of a solvent with said fiber and is concluded after a time range.
  • an increase in temperature/a temperature increase reduces the duration between first contact of a solvent/first contact of a solvent with said fiber and start of the shrinkage/shrinkage process ("time to shrink"), and/or that an increase in temperature/a temperature increase reduces the time range in which the shrinkage is concluded (“shrinkage duration").
  • an increase in pH towards a more basic pH reduces the time range in which the shrinkage (process) is concluded (“shrinkage duration").
  • the entire shrinkage process (which starts after a duration after first contact with a chemical, e.g. a solvent, and ends with the shrinkage conclusion after a time range) completely takes place in the chemical, e.g. the solvent.
  • the fiber is coated/finished.
  • the inventors of the present patent application surprisingly found that the coating may effect the shrinkage behavior.
  • a coating/finishing may prolong the duration between first contact of a solvent/first contact of a solvent with said fiber and start of the shrinkage/shrinkage process ("time to shrink"), and/or prolong the time range in which the shrinkage is concluded (“shrinkage duration").
  • the shrinkage (process) takes place at a temperature of between 8°C and 37°C, e.g. between 15°C and 25°C.
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent or the solvent with the shrinkable biopolymer fiber is between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C.
  • the shrinkage (process) takes place at a pH of between 2.8 and 12.2, e.g. between pH 6 and 8.
  • the pH of the solvent is between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the senor allows to determine the authenticity of a product.
  • said fiber shows a shrinkage of at least 10% with regard to its total length after first contact with a solvent. It is more preferred that said fiber shows a shrinkage of at least 15% with regard to its total length after first contact with a solvent. It is even more preferred that said fiber shows a shrinkage of at least 25% with regard to its total length after first contact with a solvent. It is most preferred that said fiber shows a shrinkage of at least 35% with regard to its total length after first contact with a solvent. For example, said fiber shows a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after first contact with a solvent.
  • said fiber shows a shrinkage of between 10% and 50% with regard to its total length after first contact with a solvent. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after first contact with a solvent. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after first contact with a solvent.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact with a solvent.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage is indicative for the authenticity of a product.
  • the shrinkage (process) starts between 3 and 200 seconds after first contact with the solvent. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the solvent. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after first contact with the solvent.
  • the shrinkage (process) starts between 3 and 200 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, between 17 and 47 seconds, after first contact with the solvent.
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g.
  • the temperature may be, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after first contact with the solvent at a temperature of between 24 and 35 °C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25 and 45 seconds after first contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the solvent may be an aqueous solution or a solution comprising alcohol. It is preferred that the aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O. It is also preferred that the alcohol is ethanol or isopropanol.
  • aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O.
  • H 2 O water
  • the alcohol is ethanol or isopropanol.
  • the product is a fabric, e.g. a woven fabric or knitted fabric. More preferably, the fabric, e.g. the woven fabric or knitted fabric, is a garment.
  • the shrinkable biopolymer fiber is part of a label or hangtag.
  • the label or hangtag is a piece of cloth. It is clear for the skilled person that the label or hangtag comprises more than one fiber. It is, in fact, composed of a plurality of fibers. In other words, the label or hangtag comprises or consists of fibers.
  • the label or hangtag may be a woven cloth. In this case, it is clear for the skilled person that the label or hangtag comprises or consists of fibers which are weaved to each other. It will also be understood by the skilled person that the shrinkage in a single biopolymer fiber takes place one-dimensional. In contrast thereto, the shrinkage in a woven cloth comprising or consisting of biopolymer fibers which are weaved to each other takes place multidimensional.
  • the label or hangtag may further comprise written or printed information about the product.
  • the label or hangtag may be affixed/attached to the product or is part of the product. If the label or hangtag is part of the product, it is, for example, supplied with the product. Alternatively, the label or hangtag is affixed/attached to the packaging or is part of the packaging comprising the product. That means that the label or hangtag is not directly affixed/attached to the product itself but affixed/attached to the overpack with which the product is distributed/sold.
  • the senor allows to determine the presence of a solvent/the presence of a solvent at any time in the past, e.g. water.
  • the water may be piped water, rainwater, or seawater.
  • said fiber shows a shrinkage of at least 10% with regard to its total length after first contact with a solvent. It is more preferred that said fiber shows a shrinkage of at least 15% with regard to its total length after first contact with a solvent. It is even more preferred that said fiber shows a shrinkage of at least 25% with regard to its total length after first contact with a solvent. It is most preferred that said fiber shows a shrinkage of at least 35% with regard to its total length after first contact with a solvent. For example, said fiber shows a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after first contact with a solvent.
  • said fiber shows a shrinkage of between 10% and 50% with regard to its total length after first contact with a solvent. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after first contact with a solvent. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after first contact with a solvent.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact with a solvent.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage is indicative for the presence of a solvent/the presence of a solvent at any time in the past, e.g. water.
  • the water may be piped water, rainwater, or seawater.
  • the shrinkage (process) starts between 3 and 200 seconds after first contact with the solvent. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the solvent. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after first contact with the solvent.
  • the shrinkage (process) starts between 3 and 200 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after first contact with the solvent.
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g.
  • the temperature may be, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after first contact with the solvent at a temperature of between 24 and 35 °C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25 and 45 seconds after first contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the solvent may be an aqueous solution, e.g. water.
  • the water may be piped water, rainwater, or seawater.
  • the biopolymer is a silk polypeptide. It is more preferred that the biopolymer is a recombinant silk polypeptide.
  • the (recombinant) silk polypeptide may be a spider silk polypeptide, e.g. a major ampullate silk polypeptide such as a dragline silk polypeptide, a minor ampullate silk polypeptide, or a flagelliform silk polypeptide of an orb-web spider (e.g. Araneidae or Araneoids), an insect silk polypeptide, a mussel byssus silk polypeptide, or a mixture thereof.
  • the orb-web spider may be selected from the group consisting of Araneus diadematus, Nephila clavipes, and Latrodectus hesperus.
  • the insect silk polypeptide may be of Lepidoptera, particularly Bombycidae such as Bombyx mori.
  • the insect silk polypeptide may also be of Hymenoptera, particularly AINa such as Anthophila.
  • the silk polypeptide is a spider silk polypeptide, more preferably a recombinant spider silk polypeptide.
  • the silk polypeptide is a polypeptide with an amino acid sequence which comprises or consists of at least 50%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% multiple copies of repetitive units. It is more preferred that the silk polypeptide is a polypeptide with an amino acid sequence which comprises or consists of at least 95% multiple copies of repetitive units. Said repetitive units may be identical or different. It is particularly preferred that the silk polypeptide comprises at least two identical repetitive units. For example, the silk polypeptide may comprise between 2 to 100 repetitive units, e.g.
  • the silk polypeptide consists of between 40 to 3000 amino acids. It is more preferred that the silk polypeptide consists of between 40 to 1500 amino acids. It is even more preferred that the silk polypeptide consists of between 200 to 1200 amino acids. It is most preferred that the silk polypeptide consists of between 250 to 600 amino acids.
  • the silk polypeptide comprises at least two identical repetitive units.
  • the repetitive units are independently selected from the group consisting of module C (SEQ ID NO: 1) or a variant thereof, module C Cys (said module may also be designated as module C C ) (SEQ ID NO: 2), and module C kappa (SEQ ID NO: 3).
  • Module C Cys (SEQ ID NO: 2) is a variant of module C (SEQ ID NO: 1).
  • the amino acid S (Ser) at position 25 has been replaced by the amino acid C (Cys).
  • Module C kappa (SEQ ID NO: 3) is also a variant of module C (SEQ ID NO: 1).
  • the amino acid E (Glu) at position 20 has been replaced by the amino acid K (Lys).
  • the module C variant differs from the reference module C from which it is derived by up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 amino acid changes in the amino acid sequence (i.e. substitutions, additions, insertions, deletions, N-terminal truncations and/or C-terminal truncations).
  • Such a module variant can alternatively or additionally be characterised by a certain degree of sequence identity to the reference module from which it is derived.
  • the module C variant has a sequence identity of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or even 99.9% to the respective reference module C.
  • the sequence identity is over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 27, 28, 30, 34, 35, or more amino acids, preferably over the whole length of the respective reference module C.
  • sequence identity may be at least 80% over the whole length, may be at least 85% over the whole length, may be at least 90% over the whole length, may be at least 95% over the whole length, may be at least 98% over the whole length, or may be at least 99% over the whole length of the respective reference module C.
  • sequence identity may be at least 80% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids, may be at least 85% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids, may be at least 90% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids, may be at least 95% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids, may be at least 98% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids, or may be at least 99% over a continuous stretch of at least 5, 10, 15, 18, 20, 24, 28, or 30 amino acids of the respective reference module C.
  • a fragment (or deletion) variant of module C has preferably a deletion of up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 amino acids at its N-terminus and/or at its C-terminus.
  • the deletion can also be internally.
  • module C variant or fragment is only regarded as a module C variant or fragment within the context of the present invention, if the modifications with respect to the amino acid sequence on which the variant or fragment is based do not negatively affect the ability of the silk polypeptide to act as a sensor.
  • the skilled person can readily assess whether the silk polypeptide comprising a module C variant or fragment is still capable acting as a sensor, e.g. which allows to determine the authenticity of a product or to determine the presence of a solvent. In this respect, it is referred to the shrinkage examples comprised in the experimental part of the present patent application.
  • C Cys or C kappa variants may also be encompassed by the present invention.
  • the same explanations/definitions apply which have been made with respect to the module C variant (see above).
  • the silk polypeptide comprises at least one non-repetitive (NR) unit.
  • Said non-repetitive (NR) unit may be comprised at the N- and/or C-terminus.
  • the NR unit is selected from the group consisting of NR3 (SEQ ID NO: 4) or a variant thereof, NR4 (SEQ ID NO: 5) or a variant thereof, NR5 (SEQ ID NO: 6) or a variant thereof, and NR6 (SEQ ID NO: 7) or a variant thereof.
  • the NR3 (SEQ ID NO: 4) unit is based on the amino acid sequence of ADF-3 of the spider Araneus diadematus and the NR4 (SEQ ID NO: 5) unit is based on the amino acid sequence of ADF-4 of the spider Araneus diadematus ( WO 2006/008163 ).
  • the NR5 (SEQ ID NO: 6) unit and the NR6 (SEQ ID NO: 7) unit are derived from Latrodectus hesperus.
  • a NR3, NR4, NR5, or NR6 unit variant or fragment is only regarded as a NR3, NR4, NR5, or NR6 unit variant or fragment within the context of the present invention, if the modifications with respect to the amino acid sequence on which the variant or fragment is based do not negatively affect the ability of the silk polypeptide to act as a sensor.
  • the skilled person can readily assess whether the silk polypeptide comprising a NR3, NR4, NR5, or NR6 unit variant or fragment is still capable acting as a sensor, e.g. which allows to determine the authenticity of a product or to determine the presence of a solvent. In this respect, it is referred to the shrinkage examples comprised in the experimental part of the present patent application.
  • the silk polypeptide is selected from the group consisting of (C) m , (C CyS )m, (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C CyS (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , c kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a specific shrinkage behavior. Said shrinkage behavior is further influenceable/influenced by the thickness (diameter) of the biopolymer fiber. More particularly, the shrinkage (process) starts after a duration after first contact with a solvent/after first contact of a solvent with said fiber and is concluded after a time range.
  • the inventors of the present patent application surprisingly found that an increase in the thickness (diameter) of the biopolymer fiber increases the duration between first contact of a solvent/first contact of a solvent with said fiber and start of the shrinkage (process), and/or that an increase in the thickness (diameter) of the biopolymer fiber increases the time range in which the shrinkage is concluded.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. More preferably, the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m. It is further preferred that the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a specific shrinkage behavior which is influenceable/influenced by the following factors: temperature, pH, and/or the thickness (diameter) of the biopolymer fiber.
  • the shrinkage behavior may be influenceable/influenced by additional factors.
  • the inventors of the present patent application surprisingly found that the extent of shrinkage with regard to the total length of the biopolymer fiber can be influenced by the type of biopolymer fiber used as a starting material.
  • the extent of shrinkage with regard to the total length of the biopolymer fiber is influenceable/influenced by the degree of drawing of the biopolymer fiber used as a starting material.
  • the biopolymer fiber may be a single-drawn or a multi-drawn (e.g. double-drawn) fiber. Said fiber has been stretched one or more times during its preparation process, in particular wet-spinning process.
  • the extend of shrinkage with regard to the total length of the biopolymer fiber is higher, the higher the degree of drawing of the biopolymer fiber used as a starting material is.
  • the extend of shrinkage can be adjusted to the range of 10% and 50% by varying the degree of drawing of the biopolymer fiber during and/or after the spinning process. More preferably the extend of shrinkage can be adjusted to the range of 10% and 35% by varying the degree of drawing of the biopolymer fiber during and/or after the spinning process.
  • the extend of shrinkage is higher with regard to the total length of the biopolymer fiber with a multi-drawn (e.g. double-drawn) biopolymer fiber (e.g. at least 20%) than with a single-drawn biopolymer fiber (e.g. at least 10%).
  • the biopolymer fiber has a specific shrinkage behavior which is influenceable/influenced by the following factors: temperature, pH, the thickness (diameter) of the biopolymer fiber, and/or the type of the biopolymer fiber used as a starting material (e.g. single-drawn or multi-drawn biopolymer fiber).
  • the present invention relates to a sensoring method, wherein a shrinkable biopolymer fiber is used.
  • the present invention relates to a method for determining the authenticity of a product comprising the steps of:
  • the inventors of the present invention surprisingly found that the ability of a biopolymer fiber to shrink allows its use as a sensor. They noticed that said shrinkable biopolymer fiber allows to determine the authenticity of a product in an effective, inexpensive, and user friendly way.
  • the product is a fabric, e.g. a woven fabric or knitted fabric. More preferably, the fabric, e.g. the woven fabric or knitted fabric, is a garment.
  • the product may also be a bag (e.g. a handbag) or footwear.
  • a shrinkable biopolymer fiber is provided as sensor.
  • the biopolymer is a silk polypeptide.
  • the biopolymer is more preferred that the biopolymer is a recombinant silk polypeptide.
  • the (recombinant) silk polypeptide may be a spider silk polypeptide, e.g. a major ampullate silk polypeptide such as a dragline silk polypeptide, a minor ampullate silk polypeptide, or a flagelliform silk polypeptide of an orb-web spider (e.g. Araneidae or Araneoids), an insect silk polypeptide, a mussel byssus silk polypeptide, or a mixture thereof.
  • the orb-web spider may be selected from the group consisting of Araneus diadematus, Nephila clavipes, and Latrodectus hesperus.
  • the insect silk polypeptide may also be of Hymenoptera, particularly a such as Anthophila.
  • the silk polypeptide is a spider silk polypeptide, more preferably a recombinant spider silk polypeptide.
  • the silk polypeptide is a polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • Said non-repetitive (NR) unit may be comprised at the N- and/or C-terminus.
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys )m, (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C Cys (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the shrinkable biopolymer fiber is part of a label or hangtag.
  • the label or hangtag is a piece of cloth. It is clear for the skilled person that the label or hangtag comprises more than one fiber. It is, in fact, composed of a plurality of fibers. In other words, the label or hangtag comprises or consists of fibers.
  • the label or hangtag may be a woven cloth. In this case, it is clear for the skilled person that the label or hangtag comprises or consists of fibers which are weaved to each other.
  • the label or hangtag may further comprise written or printed information about the product.
  • the label or hangtag may be affixed/attached to the product or is part of the product. If the label or hangtag is part of the product, it is, for example, supplied with the product. Alternatively, the label or hangtag is affixed/attached to the packaging or is part of the packaging comprising the product. That means that the label or hangtag is not directly affixed/attached to the product itself but affixed/attached to the overpack with which the product is distributed/sold.
  • step (ii) of the method of the second aspect of the present invention said shrinkable biopolymer fiber is/was contacted with a solvent.
  • the contact of the shrinkable biopolymer fiber with the solvent may occur/occurred by dropping the solvent onto said shrinkable biopolymer fiber, by dipping said shrinkable biopolymer fiber into the solvent, or by spraying the solvent onto said shrinkable biopolymer fiber.
  • the shrinkable biopolymer fiber is part of a label or hangtag.
  • the label or hangtag comprises or consists of fibers.
  • the solvent is/was dropped onto the label or hangtag comprising or consisting of fibers
  • the label or hangtag comprising or consisting of fibers is/was dipped into the solvent
  • the solvent is/was sprayed onto the label or hangtag comprising or consisting of fibers.
  • the label or hangtag may remain on the product or on the packaging comprising the product.
  • the label or hangtag may be removed from the product in order to contact said label or hangtag with a solvent.
  • it may also only partially be removed from the product in order to contact said label or hangtag with a solvent.
  • the solvent may be an aqueous solution or a solution comprising an alcohol. It is preferred that the aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O. It is also preferred that the alcohol is ethanol or isopropanol.
  • step (iii) of the method of the second aspect of the present invention it is observed whether a shrinkage of said fiber after contact with the solvent occurs/occurred at any time in the past. Said shrinkage takes place/starts after (first) contact with the solvent in step (ii).
  • the shrinkage is optically recognizable.
  • the shrinkage can also be measured. For example, the length of the fiber may be measured before and after contact with the solvent in order to determine whether a shrinkage occurs/takes place/starts.
  • a shrinkage of at least 10%, preferably of at least 15%, more preferably of at least 25%, even more preferably of at least 35%, with regard to the total length of said fiber is indicative for the authenticity of the product.
  • a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to the total length of said fiber is indicative for the authenticity of the product.
  • a shrinkage of between 10% and 50% with regard to the total length of said fiber is indicative for the authenticity of the product. It is more preferred that a shrinkage of between 15% and 35% with regard to the total length of said fiber is indicative for the authenticity of the product. It is even more preferred that a shrinkage of between 15% and 25% with regard to the total length of said fiber is indicative for the authenticity of the product.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage (process) starts between 3 and 200 seconds after (first) contact with the solvent. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after (first) contact with the solvent. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after (first) contact with the solvent. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after (first) contact with the solvent.
  • the shrinkage (process) starts between 3 and 200 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after (first) contact with the solvent.
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after (first) contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after (first) contact with the solvent at a temperature of between 24 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25 and 45 seconds after (first) contact with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the shrinkage in a single biopolymer fiber takes place one-dimensional.
  • the shrinkage in a woven cloth comprising or consisting of biopolymer fibers which are weaved to each other takes place multidimensional.
  • the specific shrinkage behavior of the shrinkable biopolymer fiber which is influenceable/influenced by the following factors: temperature, pH, the thickness (diameter) of the biopolymer fiber, and/or the type of the biopolymer fiber used as a starting material (e.g. single-drawn or multi-drawn biopolymer fiber), it is referred to the first aspect of the present invention.
  • the present invention relates to a method for determining the presence of a solvent comprising the steps of:
  • the inventors of the present invention surprisingly found that the ability of a biopolymer fiber to shrink allows its use as a sensor. They noticed that said shrinkable biopolymer fiber allows to determine the presence of a solvent in an effective, inexpensive, and user friendly way. In this case, the shrinkable biopolymer fiber acts as a liquid/moisture sensor.
  • the solvent may be an aqueous solution, e.g. water.
  • the water may be piped water, rainwater, or seawater.
  • the solvent may be present in an area or at a location, e.g. a shipping space, a housing space, an underground garage, or a basement room.
  • the solvent may enter the area or the location, e.g. the shipping space, the housing space, the underground garage, or the basement room.
  • the solvent may also be present in a packaging, e.g. of a product.
  • the solvent may enter this packaging, e.g. of a product. It may reduce the quality of said product or destroy the product.
  • the product may be, for example, a pharmaceutical product, a cosmetical product, an electronical product, or a mechanical product.
  • a shrinkable biopolymer fiber is provided as sensor.
  • the biopolymer is a silk polypeptide.
  • the biopolymer is more preferred that the biopolymer is a recombinant silk polypeptide.
  • the (recombinant) silk polypeptide may be a spider silk polypeptide, e.g. a major ampullate silk polypeptide such as a dragline silk polypeptide, a minor ampullate silk polypeptide, or a flagelliform silk polypeptide of an orb-web spider (e.g. Araneidae or Araneoids), an insect silk polypeptide, a mussel byssus silk polypeptide, or a mixture thereof.
  • the orb-web spider may be selected from the group consisting of Araneus diadematus, Nephila clavipes, and Latrodectus hesperus.
  • the insect silk polypeptide may also be of Hymenoptera, particularly a such as Anthophila.
  • the silk polypeptide is a spider silk polypeptide, more preferably a recombinant spider silk polypeptide.
  • the silk polypeptide is a polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • Said non-repetitive (NR) unit may be comprised at the N- and/or C-terminus
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys )m, (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C CyS (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the shrinkable biopolymer fiber is part of a thread.
  • the thread comprises or consists of shrinkable biopolymer fibers.
  • step (ii) of the method of the third aspect of the present invention it is observed whether a shrinkage of said fiber occurs/takes place/starts.
  • Said shrinkage occurs/takes place/starts after (first) contact of the solvent with said fiber.
  • the shrinkage is optically recognizable.
  • the shrinkage can also be measured. For example, the length of the fiber may be measured before and after contact with the solvent in order to determine whether a shrinkage occurs/takes place/starts.
  • a shrinkage can also be recognized by an electronical or mechanical device which provides an output (e.g. a signal or a change in state) which informs a person (e.g. the user) accordingly.
  • the shrinkage of said fiber due to the ingress of water may be recognized by an electronical or mechanical device which leads to immediate closing of the ship scotland.
  • the shrinkable biopolymer fiber is part of a ship scotland, the shrinkage of said fiber due to the ingress of water (even in small amounts) may also directly result (without interposition of an electronical or mechanical device) in the immediate closing of the ship scotland.
  • the shrinkable biopolymer fiber is part of a drug packaging, the shrinkage of said fiber due to the penetration of water informs the person (e.g.
  • the shrinkable biopolymer fiber is part of a packaging of an electronical or mechanical device, the shrinkage of said fiber due to the entry of water informs the person (e.g. the user) that the product has, possibly, a malfunction and, thus, should not be put into operation.
  • a shrinkage of at least 10%, preferably of at least 15%, more preferably of at least 25%, even more preferably of at least 35%, with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber.
  • a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber.
  • a shrinkage of between 10% and 50% with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber. It is more preferred that a shrinkage of between 15% and 35% with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber. It is even more preferred that a shrinkage of between 15% and 25% with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber.
  • a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to the total length of said fiber is indicative for the presence of a solvent in contact with said fiber.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage (process) starts between 3 and 200 seconds after contact of the solvent with said fiber. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after contact of the solvent with said fiber. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after contact of the solvent with said fiber. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after contact of the solvent with said fiber.
  • the shrinkage (process) starts between 3 and 200 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after contact of the solvent with said fiber.
  • the temperature at the time of contact between the solvent and the fiber may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after contact of the solvent with said fiber at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after contact of the solvent with said fiber at a temperature of between 24 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25 and 45 seconds after contact of the solvent with said fiber at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contact between the solvent and the fiber may be between 8°C and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the specific shrinkage behavior of the shrinkable biopolymer fiber which is influenceable/influenced by the following factors: temperature, pH, the thickness (diameter) of the biopolymer fiber, and/or the type of the biopolymer fiber used as a starting material (e.g. single-drawn or multi-drawn biopolymer fiber), it is referred to the first aspect of the present invention.
  • the present invention relates to the use of a shrinkable biopolymer fiber for shaping an object.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the object comprises or consists of a shrinkable biopolymer fiber.
  • the object comprises/consists of one single shrinkable biopolymer fiber.
  • the object comprises/consists of two or more shrinkable biopolymer fibers, e.g. a number of biopolymer fibers, or simply biopolymer fibers.
  • the object is a garment, apparel, a medical object, an orthopaedic object, a sports equipment including footwear, an outdoor equipment including footwear. It is also preferred that the object is a fabric, e.g. a woven fabric or knitted fabric. It is particularly preferred that the fabric, e.g. the woven fabric or knitted fabric, is a garment.
  • the garment may be a fashion, a sport, an outdoor, a medical, or an orthopaedic garment.
  • the garment may be fashion articles, a fashion goods, shirts, socks, stockings, e.g. compression stockings, medical stockings, or support stockings, tights, e.g. support tights, pants, e.g. sport or outdoor pants, underwear, e.g. sport or outdoor underwear, gloves, caps, storm hoods, footwear or bandages.
  • the biopolymer fiber has a specific shrinkage behavior.
  • Said specific shrinkage behavior is influenceable/influenced by temperature and/or pH.
  • the shrinkage (process) starts after a duration after first contact of the object with a solvent/after first contact of a solvent with the object and is concluded after a time range.
  • the object comprises or consists of a shrinkable biopolymer fiber.
  • the shrinkage of said fiber finally results in the shaping of the object.
  • the inventors of the present patent application surprisingly found that an increase in temperature/a temperature increase reduces the duration between first contact of the solvent with said object and start of the shrinkage/shrinkage process ("time to shrink"), and/or that an increase in temperature/a temperature increase reduces the time range in which the shrinkage is concluded ("shrinkage duration").
  • an increase in pH towards a more basic pH reduces the time range in which the shrinkage (process) is concluded.
  • the shrinkage (process) takes place at a temperature of between 8°C and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C.
  • the temperature at the time of contacting the object with the solvent or the solvent with the object is between 8°C and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C.
  • the shrinkage (process) takes place at a pH of between 2.8 and 12.2, e.g. between pH 6 and 8.
  • the pH of the solvent is between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • said fiber shows a shrinkage of at least 10% with regard to its total length after first contact of the object with a solvent. It is more preferred that said fiber shows a shrinkage of at least 15% with regard to its total length after first contact of the object with a solvent. It is even more preferred that said fiber shows a shrinkage of at least 25% with regard to its total length after first contact of the object with a solvent. It is most preferred that said fiber shows a shrinkage of at least 35% with regard to its total length after first contact of the object with a solvent.
  • said fiber shows a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after first contact of the object with a solvent. It is also preferred that said fiber shows a shrinkage of between 10% and 50% with regard to its total length after first contact of the object with a solvent. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after first contact of the object with a solvent. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after first contact of the object with a solvent.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact of the object with a solvent.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage (process) starts between 3 and 200 seconds after first contact of the object with the solvent. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after first contact of the object with the solvent. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact of the object with the solvent. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after first contact of the object with the solvent.
  • the shrinkage (process) starts between 3 and 300 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after first contact of the object with the solvent.
  • the temperature at the time of contacting the object with the solvent may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact of the object with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after first contact of the object with the solvent at a temperature of between 24 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25 and 45 seconds after first contact of the object with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the object comprises or consists of a shrinkable biopolymer fiber
  • the shrinkage of the biopolymer fiber results in the shaping of the object.
  • contacting the object with the solvent also results in contacting the shrinkable biopolymer fiber with the solvent as the object comprises or consists of the shrinkable biopolymer fiber.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contacting the shrinkable biopolymer fiber with the solvent may be between 8 and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the solvent may be an aqueous solution or a solution comprising alcohol. It is preferred that the aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O. It is also preferred that the alcohol is ethanol or isopropanol.
  • aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O.
  • H 2 O water
  • the alcohol is ethanol or isopropanol.
  • biopolymer is a silk polypeptide. It is more preferred that the biopolymer is a recombinant silk polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys ) m , (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C Cys (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a specific shrinkage behavior. Said specific shrinkage behavior is further influenceable/influenced by the thickness (diameter) of the biopolymer fiber. More particularly, the shrinkage (process) starts after a duration after first contact of the object with a solvent/after first contact of a solvent with the object and is concluded after a time range.
  • the object comprises or consists of a shrinkable biopolymer fiber. Thus, the shrinkage of said fiber finally results in the shaping of the object.
  • the biopolymer fiber has a thickness (diameter) of between 5 ⁇ m and 200 ⁇ m. More preferably, the biopolymer fiber has a thickens (diameter) of between 50 ⁇ m and 150 ⁇ m.
  • the biopolymer fiber has a specific shrinkage behavior which is influenceable/influenced by the following factors: temperature, pH, and/or the diameter of the biopolymer fiber.
  • the inventors of the present patent application surprisingly found that the extent of shrinkage with regard to the total length of the biopolymer fiber can be influenced by the type of biopolymer fiber used as a starting material.
  • the extent of shrinkage with regard to the total length of the biopolymer fiber is influenceable/influenced by the degree of drawing of the biopolymer fiber used as a starting material.
  • the biopolymer fiber may be a single-drawn or a multi-drawn (e.g. double-drawn) fiber. Said fiber has been stretched one or more times during its preparation process, in particular wet-spinning process.
  • the extend of shrinkage with regard to the total length of the biopolymer fiber is higher, the higher the degree of drawing of the biopolymer fiber used as a starting material is.
  • the extend of shrinkage is higher with regard to the total length of the biopolymer fiber with a multi-drawn (e.g. double-drawn) biopolymer fiber (e.g. at least 20%) than with a single-drawn biopolymer fiber (e.g. at least 10%).
  • the biopolymer fiber has a specific shrinkage behavior which is influenceable/influenced by the following factors: temperature, pH, the diameter of the biopolymer fiber, and/or the type of the biopolymer fiber used as a starting material (e.g. single-drawn or multi-drawn biopolymer fiber).
  • the present invention relates to a method for shaping an object, wherein a shrinkable biopolymer fiber is used.
  • the present invention relates to a method for shaping an object comprising the steps of:
  • step (i) of the method of the fifth aspect of the present invention an object comprising or consisting of shrinkable biopolymer fibers is provided.
  • the biopolymer is a silk polypeptide. It is more preferred that the biopolymer is a recombinant silk polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • Said non-repetitive (NR) unit may be comprised at the N- and/or C-terminus.
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys )m, (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C Cys (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the object comprises or consists of a shrinkable biopolymer fiber.
  • the object comprises/consists of one single shrinkable biopolymer fiber.
  • the object comprises/consists of two or more shrinkable biopolymer fibers, e.g. a number of biopolymer fibers.
  • the object is a garment, apparel, a medical object, an orthopaedic object, a sports equipment including footwear, an outdoor equipment including footwear. It is also preferred that the object is a fabric, e.g. a woven fabric or knitted fabric. It is particularly preferred that the fabric, e.g. the woven fabric or knitted fabric, is a garment.
  • the garment may be a fashion, a sport, an outdoor, a medical, or an orthopaedic garment.
  • the garment may be fashion articles, fashion goods, shirts, socks, stockings, e.g. compression stockings, medical stockings, or support stockings, tights, e.g. support tights, pants, e.g. sport or outdoor pants, underwear, e.g. sport or outdoor underwear, gloves, caps, storm hoods, footwear or bandages.
  • the object which is provided in step (i) of the method of the fifth aspect of the present invention may be mounted on a molded article, e.g. on an artificial body part.
  • the body part may also be from a living human being, e.g. a human hand in case that the object which is to be shaped is a glove or a human leg/foot in case that the object which is to be shaped is a bandage/footwear.
  • the method of the fifth aspect of the present invention thus, allows the manufacture of tailored and/or customized objects.
  • step (ii) of the method of the fifth aspect of the present invention said object is contacted with a solvent.
  • the contact of the object with the solvent may occur by dropping the solvent onto said object, by dipping said object into the solvent, or by spraying the solvent onto said object. It should be clear to the skilled person that contacting the object with the solvent also results in contacting the shrinkable biopolymer fiber with the solvent as the object comprises or consists of the shrinkable biopolymer fiber.
  • the solvent may be an aqueous solution or a solution comprising alcohol. It is preferred that the aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O. It is also preferred that the alcohol is ethanol or isopropanol.
  • aqueous solution is a buffered aqueous solution, such as Tris/HCl, or water (H 2 O), such as technical H 2 O or deionized H 2 O.
  • H 2 O water
  • the alcohol is ethanol or isopropanol.
  • the object comprises or consists of a shrinkable biopolymer fiber.
  • the biopolymer fiber comprised therein starts shrinking. This results in the shaping of the object.
  • the biopolymer fiber shows a shrinkage of at least 10%, preferably of at least 15%, more preferably of at least 25%, even more preferably of at least 35%, with regard to its total length after (first) contact of said object with the solvent.
  • the biopolymer fiber show a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after (first) contact of said object with the solvent.
  • said fiber shows a shrinkage of between 10% and 50% with regard to its total length after (first) contact of said object with the solvent. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after (first) contact of said object with the solvent. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after (first) contact of said object with the solvent.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact of said object with the solvent.
  • the shrinkage (process) starts between 3 and 200 seconds after (first) contact of the object with the solvent. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after (first) contact of the object with the solvent. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after (first) contact of the object with the solvent. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after (first) contact of the object with the solvent.
  • the shrinkage (process) starts between 3 and 200 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after (first) contact of the object with the solvent.
  • the temperature at the time of contacting the object with the solvent may be between 8 and 37°C, e.g. between 8 and 35°C, 15 and 25°C, 16 and 24°C, or 24 and 35°C, and/or the pH of the solvent may be between pH 2.8 and 12.2, e.g.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage (process) starts between 4 and 120 seconds after first contact with the solvent at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage (process) starts between 20 and 60 seconds after (first) contact of the object with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 2.8 and 12.2. It is even more preferred that the shrinkage (process) starts between 4 and 25 seconds after (first) contact of the object with the solvent at a temperature of between 24 and 35 °C, and/or at a pH of between pH 2.8 and 12.2. It is most preferred that the shrinkage (process) starts between 25and 45 seconds after (first) contact of the object with the solvent at a temperature of between 16 and 24°C, and/or at a pH of between pH 6 and 8.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the temperature at the time of contacting the object with the solvent may be between 8 and 37°C, e.g.
  • the pH of the solvent may be between pH 2.8 and 12.2, e.g. between pH 6 and 8.
  • the temperature may be 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, or 37°C and/or the pH may be pH 2.8, 2.9, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12.1, or 12.2.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 33 and 550 seconds (after start of the shrinkage (process)) at a temperature of between 8 and 35°C, and/or at a pH of between pH 2.8 and 12.2. It is more preferred that the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is concluded to at least 80%, e.g.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching. It is generally possible to re-extend the shrinked biopolymer fiber nearly to its original shape by techniques known to the person skilled in the art, e.g. by fiber extrusion, fiber extension, or fiber stretching. It is then possible to shrink the fiber by contacting said fiber with a solvent for a second time/again.
  • the inventors of the present invention noticed that the shrinkage behavior of such a biopolymer fiber differs from a biopolymer fiber which shrinks after a first contact with a solvent.
  • the shrinkage in a single biopolymer fiber takes place one-dimensional.
  • the shrinkage in an object comprising or consisting of biopolymer fibers may take place multidimensional.
  • the shrinkage in a woven cloth comprising or consisting of biopolymer fibers which are weaved to each other takes place multidimensional.
  • the method of the fifth aspect of the present invention further comprises the step of drying the object. Drying the object may be achieved by any process known to the skilled person.
  • the drying can be carried out, for example, by drying in the air, baking, using a heat chamber, a vacuum chamber, laminar flow (e.g. of a gas such as nitrogen or carbon dioxide), radiation, or a fan (at low temperatures, at room temperature or at elevated temperatures).
  • the method of the fifth aspect of the present invention further comprises the step of fixing the object. If the object is mounted on a molded article, it may be removed from said article after fixation. Fixing the object has the effect that the formed object does not change its form/shape anymore, in particular the form/shape the object has taken on the molded article.
  • the object can be fixed by chemical or physical means.
  • one or more reagents selected from the group consisting of glues and resins such as epoxy resins or polyester resins may be used.
  • the fixation of the object may occur by dropping the one or more fixation reagents onto said object, by dipping said object into the one or more fixation reagents by spraying the one or more fixation reagents onto said object, by painting said object with the one or more fixation reagents, or by applying the one or more fixation reagents onto said object with a brush.
  • the object can be fixed mechanically e.g. by knotting or clamping.
  • the object may also be mounted on a body part from a living human being, e.g. a human leg/foot in case that the object which is to be shaped is a bandage, a stocking or a footwear.
  • a living human being e.g. a human leg/foot
  • the shrinkage of the biopolymer fiber results in the compression of the body part from a living human being, e.g. the human leg. This may be desired in the field of sport, e.g. to guarantee sufficient blood flow to the heart.
  • the present invention relates to the use of a shrinkable biopolymer fiber as suture material.
  • the shrinkable biopolymer fiber can be applied as suture material to wounds.
  • the suture material is preferably a suture, e.g. a surgical suture.
  • the shrinkable biopolymer fiber may be part of a thread.
  • the thread comprises or consists of shrinkable biopolymer fibers.
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the biopolymer fiber has a specific shrinkage behavior. More particularly, the shrinkage (process) starts after a duration after first contact of the biopolymer fiber with a liquid (as solvent), e.g. a liquid present at the place of a wound such as tissue fluid, blood, or sore fluid/after first contact of a liquid, e.g. a liquid present at the place of a wound such as tissue fluid, blood, or score fluid with the biopolymer fiber and is concluded after a time range.
  • a liquid as solvent
  • the contact of the biopolymer fiber as suture with a tissue fluid, blood, or score fluid induces shrinkage of the biopolymer fiber which results in tightening the margins of the wound after suturing.
  • tissue fluid, blood as well as score fluid are aqueous solutions containing water as solvent
  • the use of the shrinkable biopolymer fiber as suture preferably allows the treatment of cuts or gaping wounds.
  • the shrinkage (process) takes place at a temperature of between 36°C and 40°C, more preferably at 37°C.
  • said fiber shows a shrinkage of at least 10% with regard to its total length after first contact with a liquid. It is more preferred that said fiber shows a shrinkage of at least 15% with regard to its total length after first contact with a liquid. It is even more preferred that said fiber shows a shrinkage of at least 25% with regard to its total length after first contact with a liquid. It is most preferred that said fiber shows a shrinkage of at least 35% with regard to its total length after first contact with a liquid. For example, said fiber shows a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after first contact with a liquid.
  • said fiber shows a shrinkage of between 10% and 50% with regard to its total length after first contact with a liquid. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after first contact with a liquid. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after first contact with a liquid.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact with a liquid.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage (process) starts between 3 and 200 seconds after first contact with the liquid. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after first contact with the liquid. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the liquid. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after first contact with the liquid.
  • the shrinkage (process) starts between 3 and 300 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after first contact with the liquid.
  • the liquid is preferably a liquid present at the place of a wound, e.g. a tissue fluid, blood, or sore fluid.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the biopolymer fiber may additionally or alternatively be wetted or moistened with another solvent, e.g. water or saline solution such as isotonic saline solution.
  • another solvent e.g. water or saline solution such as isotonic saline solution.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching.
  • the fiber is coated/finished.
  • biopolymer is a silk polypeptide. It is more preferred that the biopolymer is a recombinant silk polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys ) m , (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C Cys (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48, C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48.
  • the biopolymer fiber has a thickness (diameter) of between 5 ⁇ m and 200 ⁇ m. More preferably, the biopolymer fiber has a thickens (diameter) of between 50 ⁇ m and 150 ⁇ m.
  • the extent of shrinkage with regard to the total length of the biopolymer fiber can be influenced by the type of biopolymer fiber used as a starting material.
  • the extend of shrinkage is higher with regard to the total length of the biopolymer fiber with a multi-drawn (e.g. double-drawn) biopolymer fiber (e.g. at least 20%) than with a single-drawn biopolymer fiber (e.g. at least 10%).
  • the present invention relates to a method for suturing a wound, wherein a shrinkable biopolymer fiber is used (as suture material).
  • a shrinkable biopolymer fiber is used (as suture material).
  • the shrinkable biopolymer fiber is applied to wounds as suture material.
  • liquid at the place of the wound e.g. tissue fluid, blood, or sore fluid.
  • the contact of the biopolymer fiber as suture with the liquid induces shrinkage of the biopolymer fiber which results in tightening the margins of the wound after suturing.
  • the biopolymer fiber may additionally or alternatively be wetted or moistened with another solvent, e.g. water or saline solution such as isotonic saline solution.
  • another solvent e.g. water or saline solution such as isotonic saline solution.
  • the present invention relates to the use of a shrinkable biopolymer fiber as wound dressing.
  • the shrinkable biopolymer fiber is applied to wounds as wound dressing.
  • the wound dressing preferably comprises or consists of the shrinkable biopolymer fiber.
  • the wound dressing has the form of a tissue, woven fabric or non-woven fabric.
  • the shrinkable biopolymer fiber is part of a tissue, woven fabric or non-woven fabric.
  • the tissue, woven fabric or non-woven fabric preferably comprises or consists of the shrinkable biopolymer fiber which is used as wound dressing.
  • Techniques to produce a tissue, woven fabric or non-woven fabric out of a shrinkable biopolymer fiber are known to the skilled person.
  • the shrinkable biopolymer is part of a composite material (e.g. a plaster or bandage).
  • the biopolymer fiber has a residual moisture content of no more than 20%, e.g. no more than 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. It is more preferred that the biopolymer fiber has a residual moisture content of no more than 10%, e.g. no more than 10, 9, 8, 7, 6, 5, 4, 3, 2, 1%, or of 0%. In case of a residual moisture content of 0%, the fiber is dry. Preferably the moisture content of the fiber is between 2 % and 10 %.
  • the biopolymer fiber has a linear density of 1-700 Decitex (dtex). It is more preferred that the biopolymer fiber has a linear density of 10-300 dtex. It is even more preferred that the biopolymer fiber has a linear density of 50-250 dtex. It is most preferred that the biopolymer fiber has a linear density of 60-200 dtex.
  • the biopolymer fiber has a thickness (diameter) of between 0.5 ⁇ m and 300 ⁇ m. It is more preferred that the biopolymer fiber has a thickness (diameter) of between 1 ⁇ m and 200 ⁇ m.
  • the biopolymer fiber has a specific shrinkage behavior. More particularly, the shrinkage (process) starts after a duration after first contact of the biopolymer fiber with a liquid (as solvent), e.g. a liquid present at the place of a wound such as tissue fluid, blood, or sore fluid/after first contact of a liquid, e.g. a liquid present at the place of a wound such as tissue fluid, blood, or score fluid with the biopolymer fiber and is concluded after a time range.
  • a liquid as solvent
  • tissue fluid, blood, or score fluid tissue fluid, blood as well as score fluid are aqueous solutions containing water as solvent
  • the shrinkage (process) takes place at a temperature of between 36°C and 40°C, more preferably at 37°C.
  • said fiber shows a shrinkage of at least 10% with regard to its total length after first contact with a liquid. It is more preferred that said fiber shows a shrinkage of at least 15% with regard to its total length after first contact with a liquid. It is even more preferred that said fiber shows a shrinkage of at least 25% with regard to its total length after first contact with a liquid. It is most preferred that said fiber shows a shrinkage of at least 35% with regard to its total length after first contact with a liquid. For example, said fiber shows a shrinkage of at least 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, or 35% with regard to its total length after first contact with a liquid.
  • said fiber shows a shrinkage of between 10% and 50% with regard to its total length after first contact with a liquid. It is more preferred that said fiber shows a shrinkage of between 15% and 35% with regard to its total length after first contact with a liquid. It is even more preferred that said fiber shows a shrinkage of between 15% and 25% with regard to its total length after first contact with a liquid.
  • said fiber shows a shrinkage of between 10% and 50%, between 11% and 49%, between 12% and 48%, between 13% and 47%, between 14% and 46%, between 15% and 45%, between 16% and 44%, between 17% and 43%, between 18% and 42%, between 19% and 41%, between 20% and 40%, between 21% and 39%, between 22% and 38%, between 23% and 37%, between 24% and 36%, between 25% and 35%, between 26% and 34%, between 27% and 33%, between 28% and 32%, and between 29% and 31% with regard to its total length after first contact with a liquid.
  • the cross-sectional area of the biopolymer fiber increases.
  • the shrinkage (process) starts between 3 and 200 seconds after first contact with the liquid. It is more preferred that the shrinkage (process) starts between 4 and 120 seconds after first contact with the liquid. It is even more preferred that the shrinkage (process) starts between 20 and 60 seconds after first contact with the liquid. It is most preferred that the shrinkage (process) starts between 20 and 50 seconds after first contact with the liquid.
  • the shrinkage (process) starts between 3 and 300 seconds, between 4 and 150 seconds, between 5 and 140 seconds, between 6 and 130 seconds, between 7 and 120 seconds, between 8 and 110 seconds, between 9 and 100 seconds, between 10 and 60 seconds, between 11 and 58 seconds, between 12 and 55 seconds, between 13 and 52 seconds, between 14 and 50 seconds, between 15 and 49 seconds, between 16 and 48 seconds, or between 17 and 47 seconds after first contact with the liquid.
  • the liquid is preferably a liquid present at the place of a wound, e.g. a tissue fluid, blood, or sore fluid.
  • the shrinkage is concluded to at least 80%, e.g. at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99%, or 100%, after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is more preferred that the shrinkage is concluded to at least 90%, e.g.
  • the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)). It is even more preferred that the shrinkage is concluded to 100% after a time range of between 30 and 700 seconds, preferably of between 33 and 550 seconds, and more preferably of between 110 and 250 seconds (after start of the shrinkage (process)).
  • the biopolymer fiber may additionally or alternatively be wetted or moistened with another solvent, e.g. water or saline solution such as isotonic saline solution.
  • another solvent e.g. water or saline solution such as isotonic saline solution.
  • the shrinkage is irreversible.
  • irreversible means that the fiber does not return to its original shape without external impact/influences, in particular without force application, e.g. fiber extrusion, fiber extension, or fiber stretching.
  • biopolymer is a silk polypeptide. It is more preferred that the biopolymer is a recombinant silk polypeptide as already described under the first aspect.
  • the silk polypeptide comprises at least one non-repetitive (NR) unit as already described under the first aspect.
  • the silk polypeptide is selected from the group consisting of (C) m , (C Cys ) m , (C kappa ) m , (C) m C Cys , C Cys (C) m , (C) m C Cys (C) m , (C) m NR z , NR z (C) m and NR z (C) m NR z , , wherein m is an integer of 8 to 96, i.e.
  • the silk polypeptide is selected from the group consisting of C 8 , C 16 , C 32 , C 48 , C kappa 8 , C kappa 16 , C kappa 32 , C kappa 48 , C 8 C Cys , C 16 C Cys , C 32 C Cys , C 48 C Cys , C Cys C 8 , C Cys C 16 , C Cys C 32 , and C Cys C 48 .
  • the biopolymer fiber has a thickness (diameter) of between 5 ⁇ m and 200 ⁇ m. More preferably, the biopolymer fiber has a thickens (diameter) of between 50 ⁇ m and 150 ⁇ m.
  • the extent of shrinkage with regard to the total length of the biopolymer fiber can be influenced by the type of biopolymer fiber used as a starting material.
  • the extend of shrinkage is higher with regard to the total length of the biopolymer fiber with a multi-drawn (e.g. double-drawn) biopolymer fiber (e.g. at least 20%) than with a single-drawn biopolymer fiber (e.g. at least 10%).
  • the present invention relates to a method for treating/covering a wound with a shrinkable biopolymer fiber (as wound dressing).
  • the shrinkable biopolymer fiber is applied to wounds as wound dressing.
  • the wound dressing preferably comprises or consists of the shrinkable biopolymer fiber.
  • the wound dressing has the form of a tissue, woven fabric or non-woven fabric.
  • the shrinkable biopolymer fiber is part of a tissue, woven fabric or non-woven fabric.
  • the tissue, woven fabric or non-woven fabric preferably comprises or consists of the shrinkable biopolymer fiber which is used as wound dressing.
  • the shrinkable biopolymer is part of a composite material (e.g. a plaster or bandage).
  • the present invention By treating/covering a wound with the shrinkable biopolymer fiber, said fiber comes into contact with liquid at the place of the wound, e.g. tissue fluid, blood, or sore fluid.
  • liquid at the place of the wound e.g. tissue fluid, blood, or sore fluid.
  • the contact of the biopolymer fiber as wound dressing with the liquid induces shrinkage of the biopolymer fiber which results in tightening the margins of the wound or compression of the wound.
  • the biopolymer fiber may additionally or alternatively be wetted or moistened with another solvent, e.g. water or saline solution such as isotonic saline solution.
  • the seventh aspect of the present invention as described above, can also alternatively be worded as follows:
  • the present invention relates to a shrinkable biopolymer fiber for use as wound dressing.
  • Example 1 Determination of the starting time of the shrinkage of the fiber after first contact with a solvent and the duration between start of the shrinkage process and end of the shrinkage process
  • start of shrink In order to determine the starting time of the shrinkage/first contraction of the fiber after first contact with the solvent ("start of shrink”) and the time range (“shrinkage duration”) between start of shrink and end time/stop of the contraction of the fiber ("shrinkage conclusion”) a C 32 silk biopolymer multifiber was contacted with an aqueous solvent. The time range between contact with the solvent and start of shrink and as well as the time range between start of the shrink and end of the shrinkage (“shrinkage conclusion”) was measured.
  • the silk biopolymer was composed of 100% C 32 NR4 silk protein.
  • the silk protein was prepared as described in WO 2006/008163 .
  • the protein was then processed into fibers as described in WO 2014/037453 .
  • the fiber used for the experiments is a multifilament consisting of 40 monofilaments.
  • the fiber has an overall diameter of approximately 140 ⁇ m
  • the fiber was immersed in buffered aqueous solutions at three different pH values maintaining a constant salt content (pH 2,8 10 mM NaCl, pH 7,0 10 mM NaCl, pH 11,6 10 mM NaCl).
  • the fiber was immersed in buffered aqueous solutions at different salt contents maintaining a constant pH value (50 mM NaCl pH 7,0, 100 mM NaCl pH 7,0, 200 mM NaCl pH 7,0).
  • the biopolymer fiber has a specific shrinkage behavior which is influenced by temperature.
  • the shrinkage (process) started after a duration after first contact with a solvent/after first contact of a solvent with said fiber and was concluded after a time range.
  • An increase in temperature reduced the duration between first contact of a solvent with said fiber ("time to shrink") and start of the shrinkage.
  • time to shrink the duration between first contact of a solvent with said fiber
  • an increase in temperature reduced the time range in which the shrinkage is concluded (“shrinkage conclusion”).
  • the biopolymer fiber has a specific shrinkage behavior which is influenced by pH: an increase in pH (towards a more basic pH) reduced the time range in which the shrinkage is concluded (“shrinkage conclusion").
  • a first silk biopolymer multifiber with a diameter of approximately 250 ⁇ m
  • a second silk biopolymer fiber with a diameter of approximately 76 ⁇ m
  • first and the second silk biopolymer fiber were immersed into a glass cylinder / measuring cylinder filled with the respective solvent.
  • the biopolymer fibers were fixed with one end at the top of the glass cylinder.
  • a metal nut fixed at the other end of the fiber served as weight to fully extended the fiber.
  • the timer was set to zero at first contact with the solvent.
  • the time range between contact with solvent and first movement of fiber contraction represents time range "time to shrink”.
  • the time range between first contraction of the fiber (“start of shrink”) and stop of the contraction of the fiber represents the shrinkage duration.
  • the first and second silk biopolymer fiber were composed of 100% C 32 NR4 silk protein.
  • the silk protein was prepared as described in WO 2006/008163 .
  • the protein was then processed into fibers as described in WO 2014/037453 .
  • the first biopolymer fiber used for the experiments was a multifilament comprising three multifilaments, each multifilament consisting of 40 monofilaments.
  • the three multifilaments were twisted into a yarn which comprises three multifilaments, each multifilament consisting of 40 monofilaments.
  • the resulting fiber has an overall diameter of approximately 250 ⁇ m.
  • the second biopolymer fiber used for the experiments was a multifilament consisting of 30 monofilaments with a diameter of approximately 76 ⁇ m.
  • first biopolymer fiber 7.5°C, 16.9°C, 22.3°C, 24.8°C
  • second biopolymer fiber 4.3°C, 15.7°C, 22.63°C, 25.0°C.
  • first and second biopolymer fiber were immersed in deionized water.
  • first and second biopolymer fiber were immersed in a buffered aqueous solution (pH 12,8 100 mM NaCl).
  • Figure 2 The results are shown in Figure 2 .
  • Figure 2 A represents the shrinkage behavior of the first biopolymer fiber.
  • Figure 2 B represents the shrinkage behavior of the second biopolymer fiber. It could be demonstrated that the biopolymer fibers have a specific shrinkage behavior which is influenced by the diameter of the fiber.
  • the shrinkage process started after a duration after first contact of a solvent with said fiber and was concluded after a time range. A decrease in diameter of the fiber reduced the time to shrink and the shrinkage duration in both experiments (deionized water and buffered aqueous solution).
  • the shrinkage behavior of the biopolymer fiber in deionized water (neutral pH) compared to the shrinkage behavior of the biopolymer fiber in buffered aqueous solution (pH 12,8) shows that an increase in pH (towards a more basic pH) reduced the time to shrink and the shrinkage duration.
  • first and second biopolymer fiber first biopolymer fiber: 7.5°C, second biopolymer fiber 4.3°C
  • the results for this lowest temperature value are not directly comparable. It should be noted that a higher temperature results in a reduction of time to shrink and shrinkage duration.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Textile Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Woven Fabrics (AREA)
  • Examining Or Testing Airtightness (AREA)
  • Knitting Of Fabric (AREA)
EP22213341.5A 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor Pending EP4202394A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16198399 2016-11-11
EP17801636.6A EP3538859A1 (de) 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor
PCT/EP2017/078784 WO2018087239A1 (en) 2016-11-11 2017-11-09 Use of a shrinkable biopolymer fiber as sensor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP17801636.6A Division EP3538859A1 (de) 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor

Publications (1)

Publication Number Publication Date
EP4202394A1 true EP4202394A1 (de) 2023-06-28

Family

ID=57442441

Family Applications (2)

Application Number Title Priority Date Filing Date
EP17801636.6A Pending EP3538859A1 (de) 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor
EP22213341.5A Pending EP4202394A1 (de) 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP17801636.6A Pending EP3538859A1 (de) 2016-11-11 2017-11-09 Verwendung einer schrumpfbaren biopolymerfaser als sensor

Country Status (5)

Country Link
US (1) US20190275193A1 (de)
EP (2) EP3538859A1 (de)
JP (3) JP7023950B2 (de)
CA (1) CA3043246A1 (de)
WO (1) WO2018087239A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016222480B4 (de) 2016-11-16 2020-02-13 Adidas Ag Bekleidungsstück, das Spinnenseide aufweist oder Schuh, der Spinnenseide aufweist, und ein entsprechendes Herstellungsverfahren
JP6337252B1 (ja) 2017-03-10 2018-06-06 Ｓｐｉｂｅｒ株式会社 高収縮人造フィブロイン繊維及びその製造方法、並びに人造フィブロイン繊維の収縮方法
JPWO2018164020A1 (ja) 2017-03-10 2020-01-16 Ｓｐｉｂｅｒ株式会社 タンパク質繊維の製造方法及び製造装置
US20200270316A1 (en) * 2017-11-10 2020-08-27 Givaudan Sa Silk Alcohol Formulations
CN111699290A (zh) * 2018-01-31 2020-09-22 丝芭博株式会社 蛋白质卷曲短纤维的制造方法
CN112567083B (zh) 2018-04-03 2023-07-07 丝芭博株式会社 高收缩人造丝心蛋白加捻纱及其制造方法、以及人造丝心蛋白加捻纱及其收缩方法
WO2019194245A1 (ja) 2018-04-03 2019-10-10 Ｓｐｉｂｅｒ株式会社 高収縮人造フィブロイン紡績糸及びその製造方法、並びに人造フィブロイン紡績糸及びその収縮方法
EP3779031A4 (de) * 2018-04-03 2022-09-21 Spiber Inc. Gewebe mit hoher dichte und verfahren zu seiner herstellung
CN112714813A (zh) * 2018-09-28 2021-04-27 丝芭博株式会社 改性丝心蛋白纤维
EP3859062A4 (de) * 2018-09-28 2023-01-11 Shima Seiki Mfg., Ltd. Verfahren zur herstellung eines gesponnenen proteingarns
CN113692460B (zh) * 2019-02-07 2024-04-26 丝芭博株式会社 重组结构蛋白质复丝及其制造方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358451A1 (de) * 1988-09-09 1990-03-14 Minnesota Mining And Manufacturing Company Durch Wärme schrumpfbarer Bandagenüberzug
WO2002006789A2 (en) * 2000-07-13 2002-01-24 The Ohio State University Research Foundation Multimeric biopolymers as structural elements, sensors and actuators in microsystems
WO2003060099A2 (en) 2002-01-11 2003-07-24 Nexia Biotechnologies, Inc. Methods and apparatus for spinning spider silk protein
WO2006002827A1 (en) 2004-06-25 2006-01-12 Technische Universitaet Muenchen Proteins of natural origin and materials made therefrom
WO2006008163A2 (en) 2004-07-22 2006-01-26 Technische Universitaet Muenchen Recombinant spider silk proteins
US20110297904A1 (en) * 2008-05-02 2011-12-08 The University Of Akron Humidity responsive materials and systems and methods using humidity responsive materials
WO2014037453A1 (en) 2012-09-06 2014-03-13 Amsilk Gmbh Methods for producing high toughness silk fibres

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60127544U (ja) * 1984-02-06 1985-08-27 上古　俊寛 水分報知器
JPH0663900B2 (ja) * 1985-08-30 1994-08-22 日本電信電話株式会社 浸水検知センサ
JPH07252746A (ja) * 1994-03-09 1995-10-03 Toru Takada シルククレープタオル及びその製造方法
JPH0931798A (ja) * 1995-07-07 1997-02-04 Toru Takada シルク・ビロード布地又は編地とその製造方法
US7625951B2 (en) * 2000-07-13 2009-12-01 University Of Kentucky Research Foundation Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals
DE102009016194A1 (de) 2008-04-23 2009-10-29 Heidelberger Druckmaschinen Ag Verfahren zur Herstellung eines Sicherheitsmerkmals auf einem flachen Substrat
WO2010123450A1 (en) 2009-04-22 2010-10-28 Spiber Technologies Ab Method of producing polymers of spider silk proteins
EP2868782B1 (de) 2012-06-28 2020-07-15 Spiber Inc. Spinngefärbte proteinfaser und verfahren zur herstellung davon
US10532548B2 (en) 2013-10-21 2020-01-14 The North Face Apparel Corp. Functional biomaterial coatings for textiles and other substrates

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358451A1 (de) * 1988-09-09 1990-03-14 Minnesota Mining And Manufacturing Company Durch Wärme schrumpfbarer Bandagenüberzug
WO2002006789A2 (en) * 2000-07-13 2002-01-24 The Ohio State University Research Foundation Multimeric biopolymers as structural elements, sensors and actuators in microsystems
WO2003060099A2 (en) 2002-01-11 2003-07-24 Nexia Biotechnologies, Inc. Methods and apparatus for spinning spider silk protein
WO2006002827A1 (en) 2004-06-25 2006-01-12 Technische Universitaet Muenchen Proteins of natural origin and materials made therefrom
WO2006008163A2 (en) 2004-07-22 2006-01-26 Technische Universitaet Muenchen Recombinant spider silk proteins
US20110297904A1 (en) * 2008-05-02 2011-12-08 The University Of Akron Humidity responsive materials and systems and methods using humidity responsive materials
WO2014037453A1 (en) 2012-09-06 2014-03-13 Amsilk Gmbh Methods for producing high toughness silk fibres

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"A multilingual glossary of biotechnological terms: (IUPAC Recommendations", 1995, HELVETICA CHIMICA ACTA
SHAO ZHENGZHONG, YOUNG ROBERT J., VOLLRATH FRITZ: "The effect of solvents on spider silk studied by mechanical testing and single-fibre Raman spectroscopy", INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, vol. 24, no. 2-3, 1 March 1999 (1999-03-01), NL , pages 295 - 300, XP055885162, ISSN: 0141-8130, DOI: 10.1016/S0141-8130(98)00093-2

Also Published As

Publication number Publication date
US20190275193A1 (en) 2019-09-12
JP7454002B2 (ja) 2024-03-21
WO2018087239A1 (en) 2018-05-17
JP2024069360A (ja) 2024-05-21
EP3538859A1 (de) 2019-09-18
JP2020513542A (ja) 2020-05-14
JP2022070935A (ja) 2022-05-13
CA3043246A1 (en) 2018-05-17
JP7023950B2 (ja) 2022-02-22

Similar Documents

Publication Publication Date Title
JP7454002B2 (ja) 収縮性バイオポリマー繊維の使用
Qin Medical textile materials
KR102123170B1 (ko) 압전 기재, 압전 직물, 압전 편물, 압전 디바이스, 힘 센서, 액추에이터 및 생체 정보 취득 디바이스
King et al. Biotextiles as medical implants
JP2018500470A (ja) シルク性能衣服及び製品、並びにこれらを製造する方法
JP6818023B2 (ja) 圧電基材、圧電織物、圧電編物、圧電デバイス、力センサー、及びアクチュエータ
CA2793146C (en) Compression textile comprising chitosan coated fibres
JP6789312B2 (ja) 圧電基材、センサー、アクチュエーター、生体情報取得デバイス、及び圧電繊維構造体
CN110088366B (zh) 抗菌纤维
CA2278367C (en) Identification or control arrangements
CN110709544A (zh) 用于应对菌的电荷产生纱线、用于应对菌的电荷产生纱线的制造方法和抗菌性布帛
Kuffner et al. Wool fibres
KR20190054967A (ko) 지역적 특성을 갖는 생제작된 가죽 물품
BR0315465A (pt) Fios, fibras ou filamentos, artigo compósito, processo de fabricação de fios, fibras ou filamentos, uso de sulfeto de zinco e artigo
JP6829760B2 (ja) 圧電基材、力センサー及びアクチュエータ
WO2022197871A1 (en) Silk coated synthetic fabrics
WO2019158531A1 (en) Surgical gauze
CA2946763A1 (en) Surgical suture adapted for enhanced visibility
BR0309312A (pt) Composição de tratamento para a indústria têxtil, tecido ou produto têxtil, método para tratamento do mesmo e sistema para tratamento de produtos têxteis
Vora Design & Development of Surgical Gowns to Enhance Its Performance
GB9704330D0 (en) Self monitoring graded compression anti-thrombosis stocking
Rogina-Car et al. TENCEL with a microbial barrier for medical bras
ATE323793T1 (de) Antimikrobielle polymere
Uddin Novel technical textile yarns
Gupta et al. Recent Advancements in

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 3538859

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231110

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA